journal article·2025-12Open access

Overcoming chemoresistance via NO-mediated HSP inhibition using hybrid membrane-coated multifunctional nanoplatforms

Maierhaba Aili, Fangrui Lin, Yu Chen, Nuernisha Alifu, Rong Ma, Chenyang Chu, Jiabao Xiong, Yaqi Cui, Zhong Du, Cailing Ma, Biao Dong, Junle Qu

Abstract

Chemotherapy resistance and the precise delivery as well as controlled release of drugs at tumor sites remain major challenges in cancer treatment. Heat shock proteins (HSPs) have been identified as key contributors to chemotherapy resistance, yet effective strategies to overcome this issue are still lacking. In this study, we developed a hybrid biomimetic nanoparticle system (CuS-PTX-ICG-L-arg@HR) that integrates photothermal therapy (PTT), chemotherapy, and gas therapy to enhance the efficiency of cervical cancer treatment. By fusing the red blood cell membranes with HeLa cell membranes, the nanoparticles combined immune evasion capabilities with tumortargeting properties, and further improved circulation time and tumor accumulation. To address chemotherapy resistance, we leveraged a novel light-activated nitric oxide (NO) generation strategy, where L-arginine (L-arg) was introduced as a NO precursor to inhibit HSPs expression under near-infrared (NIR) irradiation. To the best of our knowledge, this represents the first attempt to overcome chemotherapy resistance through HSPs inhibition via NO generation, significantly enhancing the efficacy of paclitaxel (PTX) in drug-resistant tumors. Furthermore, the plasmonic properties of hollow copper sulfide (CuS) nanoparticles enable light-triggered drug release and localized therapeutic effects, ensuring precise tumor targeting and reducing off-target toxicity. This multifunctional nanoplatform offers a promising strategy for improving drug delivery, reversing chemotherapy resistance and advancing precision cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Bray · CA Cancer J. Clin. · 2024 · 74 · 229
2. Zhai · Int. J. Wom. Health · 2024 · 16 · 177510.2147/IJWH.S485515 ↗
3. Tian · Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany) · 2021 · 8
4. Yu · Chem. Eng. J. · 2025 · 520
5. Chauhan · Cancer Res. · 2025 · 85 · 557410.1158/1538-7445.AM2025-5574 ↗
6. Liu · Nano Today · 2025 · 62
7. Lu · Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany) · 2025 · 12
8. Vasan · Nature · 2019 · 575 · 29910.1038/s41586-019-1730-1 ↗
9. Rutherford · Nature · 1998 · 396 · 33610.1038/24550 ↗
10. Kiang · FASEB J. · 1998 · 12 · 157110.1096/fasebj.12.14.1571 ↗
11. Sha · Int. Immunopharmacol. · 2023 · 12210.1016/j.intimp.2023.110492 ↗
12. Han · Asian Pac. J. Cancer Prev. APJCP · 2014 · 15 · 704310.7314/APJCP.2014.15.17.7043 ↗
13. Li · Oxid. Med. Cell. Longev. · 2021 · 2021
14. Tissiéres · J. Mol. Biol. · 1974 · 84 · 38910.1016/0022-2836(74)90447-1 ↗
15. Macario · New Engl. J Med. · 2005 · 353 · 148910.1056/NEJMra050111 ↗
16. Kong · Small · 2025 · 21
17. Zuo · Small · 2025
18. Chen · Chem. Eng. J. · 2020 · 390
19. Hu · MedComm · 2022 · 3
20. Yuan · Int. J. Biol. Macromol. · 2025 · 31010.1016/j.ijbiomac.2025.143266 ↗
21. Karademir · Med. Oncol. (Northwood) · 2023 · 40 · 25010.1007/s12032-023-02126-2 ↗
22. Shin · J. Dermatol. Sci. · 2018 · 90 · 35710.1016/j.jdermsci.2018.02.004 ↗
23. Materials today
24. Europ. Respirator. Rev.: Off
25. Liu · J. Nanobiotechnol. · 2021 · 19 · 44310.1186/s12951-021-01078-x ↗
26. Zheng · Int. J. Nanomed. · 2022 · 17 · 321710.2147/IJN.S364264 ↗
27. Lin · ACS Appl. Mater. Interfaces · 2025 · 17 · 2018410.1021/acsami.5c00396 ↗
28. Ren · Int. J. Biol. Macromol. · 2023 · 23810.1016/j.ijbiomac.2023.124087 ↗
29. Su · Asian J. Pharm. Sci. · 2025 · 20
30. Sung · Nat. Nanotechnol. · 2019 · 14 · 116010.1038/s41565-019-0570-3 ↗
31. Salimian Rizi · Trends Cancer · 2017 · 3 · 65910.1016/j.trecan.2017.07.005 ↗
32. Guo · J. Colloid Interf. Sci. · 2025 · 679 · 30710.1016/j.jcis.2024.10.071 ↗
33. Tang · Chem. Commun. (Cambridge, England) · 2024 · 60 · 116010.1039/D3CC04196D ↗
34. Hu · Adv. Funct. Mater. · 2023
35. Dallavalle · 2020 · vol. 50
36. Dai · Chem. Commu. (Cambridge, England) · 2025 · 61 · 248410.1039/D4CC05660D ↗
37. Zheng · Mol. Pharm. · 2011 · 8 · 44710.1021/mp100301t ↗
38. Pan · Nanoscale · 2018 · 10 · 211510.1039/C7NR07495F ↗
39. Kuo · Biomaterials · 2012 · 33 · 327010.1016/j.biomaterials.2012.01.035 ↗
40. Ma · Biomaterials · 2013 · 34 · 770610.1016/j.biomaterials.2013.07.007 ↗
41. Zhao · Biomaterials · 2014 · 35 · 603710.1016/j.biomaterials.2014.04.019 ↗
42. Li · J. Colloid Interface Sci. · 2022 · 605 · 29610.1016/j.jcis.2021.07.092 ↗
43. Cai · Acta Biomater. · 2021 · 127 · 27610.1016/j.actbio.2021.03.051 ↗
44. Du · Chem. Eng. J. · 2025 · 520
45. Liang · Nano Lett. · 2019 · 19 · 413410.1021/acs.nanolett.9b01595 ↗
46. Cen · ACS Macro Lett. · 2020 · 9 · 155810.1021/acsmacrolett.0c00714 ↗
47. Qiu · ACS Nano · 2022 · 16 · 1706210.1021/acsnano.2c07338 ↗
48. Sun · Mol Pharma. · 2021 · 18 · 92810.1021/acs.molpharmaceut.0c00937 ↗
49. Liu · Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany) · 2024 · 11
50. Ji · Acta Biomater. · 2020 · 111 · 36310.1016/j.actbio.2020.04.046 ↗
51. Ding · Int. J. Nanomed. · 2025 · 20 · 14110.2147/IJN.S496982 ↗
52. Guo · ACS Nano · 2013 · 7 · 878010.1021/nn403202w ↗
53. Dehaini · 2017 · 29